Increased ATF2 expression predicts poor prognosis and inhibits sorafenib-induced ferroptosis in gastric cancer - Xu, Xin; Li, Yaxian; Wu, Youliang; Wang, Mingliang; Lu, Yida; Fang, Ziqing; Wang, Huizhen; Li, Yongxiang (Redox biology, 2023)
Keywords: Activating Transcription Factor 2 - genetics; Activating Transcription Factor 2 - pharmacology; Animals; ATF2; Cell Line, Tumor; Disease Models, Animal; Ferroptosis; Gastric cancer; HSPH1; Humans; Phenotype; Research Paper; Sorafenib; Sorafenib - pharmacology; Stomach Neoplasms - drug therapy; Stomach Neoplasms - genetics; ATF2; Ferroptosis; HSPH1; Gastric cancer; Sorafenib